BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 28045459)

  • 1. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
    Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Abundance and Co-occurrence of
    Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa.
    Fitzgerald CB; Shkoporov AN; Sutton TDS; Chaplin AV; Velayudhan V; Ross RP; Hill C
    BMC Genomics; 2018 Dec; 19(1):931. PubMed ID: 30547746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the relative abundance of
    Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
    Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
    Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
    J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of Faecalibacterium prausnitzii in human health: An overview.
    Leylabadlo HE; Ghotaslou R; Feizabadi MM; Farajnia S; Moaddab SY; Ganbarov K; Khodadadi E; Tanomand A; Sheykhsaran E; Yousefi B; Kafil HS
    Microb Pathog; 2020 Dec; 149():104344. PubMed ID: 32534182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
    Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
    Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile.
    Marcos-Fernández R; Riestra S; Alonso-Arias R; Ruiz L; Sánchez B; Margolles A
    Microbiol Spectr; 2023 Feb; 11(1):e0181722. PubMed ID: 36598219
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of
    Ueda A; Shinkai S; Shiroma H; Taniguchi Y; Tsuchida S; Kariya T; Kawahara T; Kobayashi Y; Kohda N; Ushida K; Kitamura A; Yamada T
    Cell Rep Med; 2021 Sep; 2(9):100398. PubMed ID: 34622235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes.
    Cornuault JK; Petit MA; Mariadassou M; Benevides L; Moncaut E; Langella P; Sokol H; De Paepe M
    Microbiome; 2018 Apr; 6(1):65. PubMed ID: 29615108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraspecific Diversity of Microbial Anti-Inflammatory Molecule (MAM) from
    Auger S; Kropp C; Borras-Nogues E; Chanput W; Andre-Leroux G; Gitton-Quent O; Benevides L; Breyner N; Azevedo V; Langella P; Chatel JM
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.
    Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W
    Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851
    [No Abstract]   [Full Text] [Related]  

  • 17. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.
    Lindstad LJ; Lo G; Leivers S; Lu Z; Michalak L; Pereira GV; Røhr ÅK; Martens EC; McKee LS; Louis P; Duncan SH; Westereng B; Pope PB; La Rosa SL
    mBio; 2021 Jun; 12(3):e0362820. PubMed ID: 34061597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of 84
    Bai Z; Zhang N; Jin Y; Chen L; Mao Y; Sun L; Fang F; Liu Y; Han M; Li G
    Front Cell Infect Microbiol; 2022; 12():919701. PubMed ID: 36683686
    [No Abstract]   [Full Text] [Related]  

  • 19. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth.
    Lopez-Siles M; Khan TM; Duncan SH; Harmsen HJ; Garcia-Gil LJ; Flint HJ
    Appl Environ Microbiol; 2012 Jan; 78(2):420-8. PubMed ID: 22101049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.